Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Dianthus Therapeutics, Inc. (DNTH) had Profit Margin of -7973.33% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.04M |
|
$-162.34M |
|
-- |
|
$2.04M |
|
$179.97M |
|
$-177.93M |
|
$15.60M |
|
$-162.34M |
|
$-162.84M |
|
$-162.34M |
|
$-162.34M |
|
$-162.34M |
|
$-162.84M |
|
$-177.93M |
|
$-183.67M |
|
38.62M |
|
38.62M |
|
$-4.20 |
|
$-4.20 |
|
| Balance Sheet Financials | |
$409.44M |
|
$0.30M |
|
$121.48M |
|
$530.92M |
|
$30.73M |
|
-- |
|
$6.79M |
|
$37.52M |
|
$493.40M |
|
$493.40M |
|
$493.40M |
|
43.22M |
|
| Cash Flow Statement Financials | |
$-129.06M |
|
$-122.83M |
|
$280.12M |
|
$23.02M |
|
$51.25M |
|
$28.23M |
|
$22.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-8739.34% |
|
-8739.34% |
|
-9021.02% |
|
-7973.33% |
|
|
Profit Margin |
-7973.33% |
$-129.27M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
39.15 |
|
9.32 |
|
-32.90% |
|
-32.90% |
|
-30.58% |
|
-32.90% |
|
$11.42 |
|
$-3.35 |
|
$-3.34 |
|